Fluvastatin for Lowering Cholesterol
Fluvastatin (Lescol - Sandoz), an HMG-CoA reductase inhibitor, was recently marketed in the USA for treatment of hypercholesterolemia. A synthetic mevalonolactone derivative, it is chemically distinct from previously available drugs in this class....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Fluvastatin for Lowering Cholesterol
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 923
Article Code: 923a
Date: May 27, 1994
Volume: 36
Pages: 45-46
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 923
Article Code: 923a
Date: May 27, 1994
Volume: 36
Pages: 45-46
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)